Criteria for referral of pediatric SARS-CoV-2 infection: a real-life experience in the pandemic era

Abstract

A practical guidance on the management of children with COVID-19 to insure homogeneous criteria for referral to a higher-level facility, according to the disease severity, is pivotal in the pandemic era. A panel of experts in pediatric infectious diseases and intensive care at the tertiary-care Meyer Children’s University Hospital, Florence, Italy, issued a practical document shared with Tuscany hospitals. The rationale was to target the referral for those children at risk of requiring an intensive support, since the above mentioned hospital has the pediatric intensive care unit. Overall, 378 patients between 0 and 19 years of age were diagnosed with COVID-19 infection in the Tuscany region with 24 (6.3%) hospitalizations. Only three children were centralized to Meyer Children’s University Hospital according to reported criteria. Considering that appropriate referral criteria have been associated with reduced mortality in other conditions, our document might be useful to improve outcomes of children with COVID-19.

To the Editor,

severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019 (COVID-19) [1]. Due to the spreading of SARS-CoV-2 in Italy, a guidance on the management of children with COVID-19 is needed in order to insure homogeneous criteria for referral to a higher-level facility, according to the disease severity. A panel of experts in pediatric infectious diseases and intensive care, currently in a multidisciplinary group for COVID-19 care at the tertiary-care Meyer Children’s University Hospital, Florence, Italy, issued a practical document that has been shared with Tuscany hospitals. The rationale was to target the referral for those children at risk of requiring an intensive support, since the above mentioned hospital has the pediatric intensive care unit.

Overall, 378 patients between 0 and 19 years of age were diagnosed with COVID-19 infection in the Tuscany region, up to 31 July 2020. Of these, 24 (6.3%) have been hospitalized in Tuscany hospitals [2]. In particular, 14 children have been admitted to Meyer Children’s University Hospital and only 3 of them (21.4%) were centralized from other hospitals (two infants because under 3 months of age and one 14 years old age with a genetic disorder). None of the children were admitted in intensive care unit.

In fact, according to the currently available data, COVID-19 in children usually presents as a asymptomatic/pauci-symptomatic disease. Asymptomatic cases do not require further evaluation unless clinical deterioration occurs. If present, clinical manifestations include fever (44–50%), dry cough (38%), asthenia. Other signs/symptoms are nasal congestion, rhinitis, headache, diarrhea, feeding difficulties [1, 3]. However, mild and severe cases are also described in children and disease severity can be classified as follows.

• Asymptomatic

• Pauci-symptomatic/uncomplicated case: fever and/or asthenia with mild upper respiratory signs, such as coryza, nasal obstruction

• Moderate case: fever and/or asthenia and/or respiratory signs/symptoms, such as cough, mild distress with polypnea and/or difficulty in feeding, signs of dehydration

• Severe case: fever and/or cough, plus at least one of the following:

• SpO2 < 92% on finger pulse oximeter taken at rest

  • Labored breathing (moaning, nasal flattering, sternal, clavicular and internal recesses.

  • ribs), cyanosis, intermittent apnea.

  • Tachypnea, in apyrexia and absence of crying (respiratory rate > 60 breaths/minute < 3 months; > 50 breaths /minute 3–12 months; > 40 breaths /minute 1–5 years; > 30 breaths/ minute > 5 years).

  • Systemic signs of worsening: lethargy, inability to feed/drink, convulsions.

  • Suspected sepsis.

  • Shock or other organ failure requiring care.

It should be underlined that the early identification of risk factors and warning indicators for severe and critical disease is of paramount importance. These includes the following criteria:

• Age < 3 months.

• Underlying diseases (e.g. congenital heart disease, bronchopulmonary dysplasia, respiratory tract malformation, cystic fibrosis, hemoglobinopathies, severe malnutrition, abnormal hemoglobin, congenital or acquired immunodeficiencies, etc.)

• Respiratory rate increasing despite intravenous hydration and oxygen therapy with nasal cannula/mask after 2 h of treatment.

• Poor mental reaction and drowsiness.

• Lactate increasing progressively.

• Bilateral or multiple lobe lung infiltrates, pleural effusion, rapid progression of radiological changes.

• Acute respiratory distress syndrome (ARDS) [4]

According to the present document, referral of patients with SARS-Cov-2 infection is not necessary in asymptomatic or uncomplicated cases. In moderate cases, referral should be established on the basis of criteria reported in Table 1. The bedside PEWS score is a useful tool to detect changing in the clinical picture [5]. It is appropriate in the presence of warning indicators or if the local hospital is unable to guarantee an isolation room or the level of care required. All severe cases should be early referred to a tertiary-care hospital with a pediatric intensive-care facility. Considering that appropriate referral criteria have been associated with reduced mortality in other conditions [6], our document might be useful to improve outcomes of children with COVID-19.

Table 1 Referral criteria for children with COVID-19